Loss of heterozygosity at 3p in non-small cell lung cancer and its prognostic implication

Clinical Cancer Research

Volumn 2, Issue 7, 1996, Pages 1185-1189

  Mitsudomi, Tetsuya ^a,b,d   Oyama, Tsunehiro ^b   Nishida, Kinue ^b   Ogami, Akira ^b   Osaki, Toshihiro ^b   Sugio, Kenji ^a,b   Yasumoto, Kosei ^b   Sugimachi, Keizo ^a   Gazdar, Adi F ^c  

^a KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c UNIVERSITY OF TEXAS AT DALLAS   (United States)

^d AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHROMOSOMAL LOCALIZATION; CHROMOSOME 3P; CYTOGENETICS; DNA POLYMORPHISM; FEMALE; HETEROZYGOSITY; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TUMOR SUPPRESSOR GENE;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CHROMOSOMES, HUMAN, PAIR 3; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS;

EID: 0029889028     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Marshall, C J. Tumor suppressor genes. Cell, 64: 313-326, 1991.
2. Karp, J. E., and Broder, S. Molecular foundations of cancer. new targets for intervention. Nat. Med., 1: 309-320, 1995.
3. Minna, J. D. The molecular biology of lung cancer pathogenesis. Chest, 103: 445S-456S, 1993.
4. Sato, S., Nakamura, Y., and Tsuchiya, E. Differences of allelotype between squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res., 54: 5652-5655, 1994.
5. Shiseki, M., Kohno, T., Nishikawa, R , Sameshima, Y., Mizoguchi, H. and Yokota, J Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma. Cancer Res., 54; 5643-5648, 1994.
6. Whang-Peng, J., Kao-Shan, C., Lee, E., Bunn, P., Jr., Carney, D., Gazdar, A., and Minna, J. A specific chromosome defect associated with human small-cell lung cancer: deletion 3p(14-23) Science (Washington DC), 275: 181-182, 1982.
7. Hung, J., Kishimoto, Y., Sugio, K., Virmani, A., McIntire, D. D., Minna, J. D., and Gazdar, A. F. Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma. J. Am. Med. Assoc., 273: 558-563, 1995.
8. Kishimoto, Y., Sugio, K., Hung, J. Y., Virmani, A., McIntire, D. D., Minna. J D., and Gazdar, A. F. Allele-specific loss of chromosome 9p in preneoplastic lesions accompanying non-small cell lung cancers. J. Natl. Cancer Inst., 87: 1224-1229, 1995.
9. Brauch, H., Johnson, B., Hovis, J., Yano, T., Gazdar, A., Pettingill, O. S., Graziano, S., Sorenson, G. D., Poiesz, B., Minna, J., Linehan, M., and Zbar, B. Molecular analysis of the short arm of chromosome 3 in small-cell and non-small-cell carcinoma of the lung. N. Engl. J. Med., 317: 1109-1113, 1987.
10. Kok, K., Osinga, J., Carritt, B., Davis, M., vanderHout, A., vanderVeen, A., Landsvater, R., deLeiji, L., Berendsen, H., Postmus, P., Poppema, S., and Buys, C. Deletion of a DNA sequence at the chromosomal region 3p21 in all major types of lung cancer. Nature (Lond.), 330: 578-581, 1987.
11. Yokota, J., Wada, M., Shimosato, Y., Terada, M., and Sugimura, T. Loss of heterozygosity of chromosome 3, 13, and 17 in small-cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. USA, 84: 9252-9256, 1987.
12. Naylor, S. L., Johnson, B. E., Minna, J. D., and Sakaguchi, A. Loss of heterozygosity of chromosome 3p markers in small cell lung cancer. Nature (Lond ), 329: 451-454, 1987.
13. Rabbits, P., Douglas, J., Daly, M, Sundaresan, V., Fox, B., Haselton, P., Wells, F., Albertson, D., Waters, J., and Bergh, J. Frequency and extent of allelic loss in the short arm of chromosome 3 in non-small cell lung cancer. Genes Chromosomes & Cancer, 1: 95-105, 1989.
14. Hibi, K., Takahashi, T., Yamakawa, K., Ueda, R., Sekido, Y., Ariyoshi, Y., Suyama, M , Takagi, H., Nakamura, Y., and Takahashi, T. Three distinct regions involved in 3p deletion in human lung cancer. Oncogene, 7: 445-449, 1992.
15. Yokoyama, S., Yamakawa, K., Tsuchiya, E., Murata, M., Sakiyama, S., and Nakamura, Y. Deletion mapping on the short arm of chromosome 3 in squamous cell carcinoma and adenocarcinoma of the lung Cancer Res., 52: 873-877, 1992.
16. Horio, Y., Takahashi, T., Kuroishi, T., Hibi, K., Suyama, M., Niimi, T., Shimokata, K., Yamakawa, K., Nakamura, Y., Ueda, R., and Takahashi, T. Prognostic significance of p53 mutations and 3p deletions in primary resected non-small cell lung cancer. Cancer Res., 53: 1-4, 1993.
17. Kishimoto, Y., Sugio, K., Mitsudomi, T., Oyama, T., Virmani, A. K., McIntire, D. D., and Gazdar, A. F. Frequent loss of the short arm of chromosome 9 in resected non-small cell lung cancers from Japanese patients and its association with squamous cell carcinoma. J. Cancer Res. Clin. Oncol., 121: 291-296, 1995.
18. Mitsudomi, T., Steinberg, S. M., Oie, H. K., Mulshine, J L., Phelps, R , Viallet, J., Pass, H., Minna, J. D., and Gazdar, A. F ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent. Cancer Res., 51: 4999-5002, 1991.
19. Mitsudomi, T., Oyama, T., Kusano, T., Osaki, T., Nakanishi, R., and Shirakusa, T. p53 gene mutations as a predictor of poor prognosis in patients with non-small cell lung cancer. J. Natl. Cancer Inst., 85: 2018-2023, 1993.
20. Mitsudomi, T., Oyama, T., Nishida, K., Ogami, A., Osaki, T., Nakanishi, R., Sugio, K., Yasumoto, K , and Sugimachi, K. p53 nuclear immunostaining and gene mutations in non-small cell lung cancer and their effect on patient survival. Ann. Oncol., 10: S9-S13, 1995.
21. Jones, M. H., Yamakawa, K., and Nakamura, Y. Isolation and characterization of 19 dinucleotide repeat polymorphisms on chromosome 3p. Hum. Mol. Genet., 1: 131-133, 1992.
22. Kaplan, E., and Meier, P. Non-parametric estimation from incomplete observation. J. Am. Stat Assoc., 53: 457-481, 1958.
23. Mantel, N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep., 50: 163-170, 1966.
24. Cox, D. R. Regression models and life tables. J. R. Stat. Soc. Ser. B, 34: 187-220, 1972.
25. Ganly, P. S., Jarad, N., Rudd, R. M., and Rabbits, P. H. PCR-based RFLP analysis allows genotyping of the short arm of chromosome 3 in small biopsies from patients with lung cancer. Genomics, 12: 221-228, 1992.
26. Weston, A., Willey, J., Modali, R , Sugimura, H., McDowell, E., Resau, J., Light, B., Haugen, A., Mann, D., Trump, B., and Harris, C. Differential DNA sequence deletions from chromosome 3, 11, 13 and 17 in squamous-cell carcinoma, large cell carcinoma, and adenocarcinoma of the human lung. Proc. Natl. Acad. Sci. USA, 86: 5099-5103, 1989
27. Rodenhuis, S., Slebos, R , Boot, A., Evers, S., Mooi, W., Wagenaar, S., van Bodegom, P., and Bos, J. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. Cancer Res., 48: 5738-5741, 1988.
28. Chiba, I., Takahashi, T., Nau, M M., D'Amico, D., Curiel, D. T., Mitsudomi, T., Buchhagen, D. L., Carbone, D., Piantadosi, S., Koga, H., Reissman, P. T., Slamon, D. J., Holmes, E. C., Minna, J. D., and Lung Cancer Study Group. Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Oncogene, 5: 1603-1610, 1990.
29. Harbour, J. W., Lai, S-L., Whang-Peng, J., Gazdar, A. F., Minna, J. D., and Kaye, F. J Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science (Washington DC), 241: 353-357, 1988.
30. Yokota, J., Akiyama, T., Fung, Y-K., Benedict, W , Namba, Y., Hanaoka, M., Wada, M., Terasaki, T , Shimosato, Y., Sugimura, T., and Terada, M Altered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung. Oncogene, 3: 471-475, 1988.
31. Takahashi, T , Takahashi, T., Suzuki, H., Hida, T., Sekido, Y., Ariyoshi, Y., and Ueda, R. The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern. Oncogene, 6: 1775-1778, 1991.
32. D'Amico, D., Carbone, D., Mitsudomi, T., Nau, M., Fedorko, J., Russell, E., Johnson, B., Buchhagen, D , Bodner, S., Phelps, R., Gazdar, A., and Minna. J. D. High frequency of somatically acquired p53 mutations in small-cell lung cancer cell lines and tumors Oncogene, 7: 339-346, 1992
33. Mitsudomi, T., Viallet, J., Linnoila, R. I., Mulshine, J. L., Minna, J. D., and Gazdar, A. F. Mutations of ras genes distinguish a subset of non-small cell lung cancer cell lines from small cell lung cancer cell lines. Oncogene, 6: 1353-1362, 1991.
34. Nishio, M., Koshikawa, T., Kuroishi, T., Suyama, M , Uchida, K., Takagi, Y., Washimi, O., Sugiura, T., Ariyoshi, Y., Takahashi, T., Ueda, R , and Takahashi, T. Prognostic significance of abnormal p53 accumulation in primary, resected non-small-cell lung cancers. J. Clin. Oncol., 14: 497-502, 1996.
35. neu expression in human lung adenocarcinomas predicts shortened survival. Cancer Res., 50: 5184-5191, 1990.